Enhanced production and gene expression of IL-5 in bronchial asthma. Possible management of atopic diseases with IL-5 specific gene transcription inhibitor.
Mori
A
A
Department of Medicine and Physical Therapy, Faculty of Medicine, University of Tokyo, Japan.
Suko
M
M
Kaminuma
O
O
Nishizaki
Y
Y
Nagahori
T
T
Mikami
T
T
Ohmura
T
T
Hosino
A
A
Asakura
Y
Y
Okudaira
H
H
D000818:Animals; D001249:Asthma / Q000097:blood / Q000276:immunology* / Q000628:therapy; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D016572:Cyclosporine / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D015848:Interleukin-5 / Q000096:biosynthesis* / Q000235:genetics; D015759:Ionomycin / Q000494:pharmacology; D016559:Tacrolimus / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014158:Transcription, Genetic
D015848:Interleukin-5; D015759:Ionomycin; D016572:Cyclosporine; D013755:Tetradecanoylphorbol Acetate; D016559:Tacrolimus